Use of first-line treatment for Neisseria gonorrhoeae after treatment guideline changes

Sex Transm Dis. 2014 Jan;41(1):64-6. doi: 10.1097/OLQ.0000000000000061.

Abstract

After 2 notices with treatment recommendation changes for Neisseria gonorrhoeae, the Philadelphia Department of Public Health documented medical therapy for 92% (3279/3551) of cases; 3001 (92%) received a recommended therapy. Nonrecommended therapies were documented in 8% of cases. Providers diagnosing 2 or less N. gonorrhoeae cases were more likely to use nonrecommended therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Drug Administration Schedule
  • Drug Resistance, Microbial / drug effects*
  • Female
  • Gonorrhea / drug therapy*
  • Humans
  • Male
  • Neisseria gonorrhoeae / pathogenicity*
  • Practice Guidelines as Topic
  • Public Health*
  • Sentinel Surveillance

Substances

  • Anti-Bacterial Agents